Literature DB >> 25497287

Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells.

Shanthi Ganesan1, Aileen F Keating2.   

Abstract

Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent cyclophosphamide (CPA), destroys rapidly dividing cells by forming NOR-G-OH, NOR-G and G-NOR-G adducts with DNA, potentially leading to DNA damage. A previous study demonstrated that PM induces ovarian DNA damage in rat ovaries. To investigate whether PM induces DNA adduct formation, DNA damage and induction of the DNA repair response, rat spontaneously immortalized granulosa cells (SIGCs) were treated with vehicle control (1% DMSO) or PM (3 or 6μM) for 24 or 48h. Cell viability was reduced (P<0.05) after 48h of exposure to 3 or 6μM PM. The NOR-G-OH DNA adduct was detected after 24h of 6μM PM exposure, while the more cytotoxic G-NOR-G DNA adduct was formed after 48h by exposure to both PM concentrations. Phosphorylated H2AXH2AX), a marker of DNA double stranded break occurrence, was also increased by PM exposure, coincident with DNA adduct formation. Additionally, induction of genes (Atm, Parp1, Prkdc, Xrcc6, and Brca1) and proteins (ATM, γH2AX, PARP-1, PRKDC, XRCC6, and BRCA1) involved in DNA repair were observed in both a time- and dose-dependent manner. These data support that PM induces DNA adduct formation in ovarian granulosa cells, induces DNA damage and elicits the ovarian DNA repair response.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclophosphamide; DNA adduct; DNA damage; DNA repair; Granulosa cells; Phosphoramide mustard

Mesh:

Substances:

Year:  2014        PMID: 25497287      PMCID: PMC5044804          DOI: 10.1016/j.taap.2014.11.017

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.

Authors:  S A Little; P E Mirkes
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

3.  Biosynthesis of steroids by granulosa cells of the porcine ovary in vitro.

Authors:  L Bjersing; H Carstensen
Journal:  J Reprod Fertil       Date:  1967-08

4.  Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometry.

Authors:  J R Cushnir; S Naylor; J H Lamb; P B Farmer; N A Brown; P E Mirkes
Journal:  Rapid Commun Mass Spectrom       Date:  1990-10       Impact factor: 2.419

5.  DNA damage signaling in response to double-strand breaks during mitosis.

Authors:  Simona Giunta; Rimma Belotserkovskaya; Stephen P Jackson
Journal:  J Cell Biol       Date:  2010-07-26       Impact factor: 10.539

6.  Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.

Authors:  J R Mehta; D B Ludlum
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

7.  7,12-Dimethylbenz[a]anthracene exposure induces the DNA repair response in neonatal rat ovaries.

Authors:  Shanthi Ganesan; Poulomi Bhattacharya; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-19       Impact factor: 4.219

8.  Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment.

Authors:  Patrick Calsou; Christine Delteil; Philippe Frit; Jérôme Drouet; Bernard Salles
Journal:  J Mol Biol       Date:  2003-02-07       Impact factor: 5.469

9.  Involvement of a volatile metabolite during phosphoramide mustard-induced ovotoxicity.

Authors:  Jill A Madden; Patricia B Hoyer; Patrick J Devine; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2014-03-15       Impact factor: 4.219

10.  Acute ovarian failure in the childhood cancer survivor study.

Authors:  Wassim Chemaitilly; Ann C Mertens; Pauline Mitby; John Whitton; Marilyn Stovall; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 6.134

View more
  11 in total

1.  Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.

Authors:  Yi Luan; Maxwell E Edmonds; Teresa K Woodruff; So-Youn Kim
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

2.  Obesity alters phosphoramide mustard-induced ovarian DNA repair in mice.

Authors:  Shanthi Ganesan; Jackson Nteeba; Jill A Madden; Aileen F Keating
Journal:  Biol Reprod       Date:  2017-02-01       Impact factor: 4.285

3.  Low dosage use of cyclophosphamide improves the survival of patients with systemic lupus erythematosus.

Authors:  Yoosuf Ali Ashraf Muhammad Hussenbocus; Ziyi Jin; Wenyou Pan; Lin Liu; Min Wu; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Xuebing Feng; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2022-03-01       Impact factor: 2.980

Review 4.  The Role of Mutant p63 in Female Fertility.

Authors:  Yi Luan; Pauline Xu; Seok-Yeong Yu; So-Youn Kim
Journal:  Int J Mol Sci       Date:  2021-08-20       Impact factor: 5.923

5.  Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.

Authors:  Francesca Gruppi; Leila Hejazi; Plamen P Christov; Sesha Krishnamachari; Robert J Turesky; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2015-09-01       Impact factor: 3.739

6.  Nitrogen mustard exposure perturbs oocyte mitochondrial physiology and alters reproductive outcomes.

Authors:  Lynae M Brayboy; Haley Clark; Laura O Knapik; Ruby E Schnirman; Gary M Wessel
Journal:  Reprod Toxicol       Date:  2018-10-09       Impact factor: 3.143

7.  The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.

Authors:  Giovanna Di Emidio; Giulia Rossi; Isabelle Bonomo; Gonzalo Luis Alonso; Roberta Sferra; Antonella Vetuschi; Paolo Giovanni Artini; Alessandro Provenzani; Stefano Falone; Gaspare Carta; Anna Maria D'Alessandro; Fernanda Amicarelli; Carla Tatone
Journal:  Oxid Med Cell Longev       Date:  2017-11-15       Impact factor: 6.543

8.  Introduction of the α-ketoamide structure: en route to develop hydrogen peroxide responsive prodrugs.

Authors:  Tingting Meng; Jing Han; Pengfei Zhang; Jing Hu; Junjie Fu; Jian Yin
Journal:  Chem Sci       Date:  2019-06-28       Impact factor: 9.825

9.  BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy.

Authors:  Olafur A Stefansson; Holmfridur Hilmarsdottir; Kristrun Olafsdottir; Laufey Tryggvadottir; Asgerdur Sverrisdottir; Oskar T Johannsson; Jon G Jonasson; Jorunn E Eyfjord; Stefan Sigurdsson
Journal:  JNCI Cancer Spectr       Date:  2019-12-11

10.  Determination of O6-Methylguanine in dried blood spot of breast cancer patients after cyclophosphamide administration.

Authors:  Yahdiana Harahap; Athalia Theda Tanujaya; Farhan Nurahman; Aurelia Maria Vianney; Denni Joko Purwanto
Journal:  Heliyon       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.